436 related articles for article (PubMed ID: 27538058)
41. Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study.
Leurs A; Dubucquoi S; Machuron F; Balden M; Renaud F; Rogeau S; Lopez B; Lambert M; Morell-Dubois S; Maillard H; Béhal H; Hachulla E; Launay D; Sobanski V
Joint Bone Spine; 2021 Jan; 88(1):105048. PubMed ID: 32653653
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic Utility of Auto-Antibodies in Inflammatory Muscle Diseases.
Allenbach Y; Benveniste O
J Neuromuscul Dis; 2015; 2(1):13-25. PubMed ID: 28198709
[TBL] [Abstract][Full Text] [Related]
43. [Myositis specific autoantibodies as a new diagnostic criterion for idiopathic inflammatory myopathies].
Kowalska-Oledzka E; Stern LZ
Neurol Neurochir Pol; 2000; 34(2):339-47. PubMed ID: 10962726
[TBL] [Abstract][Full Text] [Related]
44. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome.
Lega JC; Fabien N; Reynaud Q; Durieu I; Durupt S; Dutertre M; Cordier JF; Cottin V
Autoimmun Rev; 2014 Sep; 13(9):883-91. PubMed ID: 24704867
[TBL] [Abstract][Full Text] [Related]
45. Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.
Lilleker JB; Rietveld A; Pye SR; Mariampillai K; Benveniste O; Peeters MT; Miller JA; Hanna MG; Machado PM; Parton MJ; Gheorghe KR; Badrising UA; Lundberg IE; Sacconi S; Herbert MK; McHugh NJ; Lecky BR; Brierley C; Hilton-Jones D; Lamb JA; Roberts ME; Cooper RG; Saris CG; Pruijn GJ; Chinoy H; van Engelen BG;
Ann Rheum Dis; 2017 May; 76(5):862-868. PubMed ID: 28122761
[TBL] [Abstract][Full Text] [Related]
46. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
Chung SW; Yoo IS; Kim J; Kang SW; Kwon M; Joung CI; Choi IA; Chang SH; Kang MI; Hong SJ; Lee YA
Yonsei Med J; 2021 May; 62(5):424-430. PubMed ID: 33908213
[TBL] [Abstract][Full Text] [Related]
47. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients.
Suzuki S; Nishikawa A; Kuwana M; Nishimura H; Watanabe Y; Nakahara J; Hayashi YK; Suzuki N; Nishino I
Orphanet J Rare Dis; 2015 May; 10():61. PubMed ID: 25963141
[TBL] [Abstract][Full Text] [Related]
48. Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients.
Platteel ACM; Wevers BA; Lim J; Bakker JA; Bontkes HJ; Curvers J; Damoiseaux J; Heron M; de Kort G; Limper M; van Lochem EG; Mulder AHL; Saris CGJ; van der Valk H; van der Kooi AJ; van Leeuwen EMM; Veltkamp M; Schreurs MWJ; Meek B; Hamann D
J Transl Autoimmun; 2019 Dec; 2():100013. PubMed ID: 32743501
[TBL] [Abstract][Full Text] [Related]
49. Diagnosis and classification of idiopathic inflammatory myopathies.
Lundberg IE; Miller FW; Tjärnlund A; Bottai M
J Intern Med; 2016 Jul; 280(1):39-51. PubMed ID: 27320359
[TBL] [Abstract][Full Text] [Related]
50. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.
Arouche-Delaperche L; Allenbach Y; Amelin D; Preusse C; Mouly V; Mauhin W; Tchoupou GD; Drouot L; Boyer O; Stenzel W; Butler-Browne G; Benveniste O
Ann Neurol; 2017 Apr; 81(4):538-548. PubMed ID: 28224701
[TBL] [Abstract][Full Text] [Related]
51. Novel serology testing for sporadic inclusion body myositis: disease-specificity and diagnostic utility.
Herbert MK; Pruijn GJ
Curr Opin Rheumatol; 2015 Nov; 27(6):595-600. PubMed ID: 26285103
[TBL] [Abstract][Full Text] [Related]
52. Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies.
Casal-Dominguez M; Pinal-Fernandez I; Pak K; Huang W; Selva-O'Callaghan A; Albayda J; Casciola-Rosen L; Paik JJ; Tiniakou E; Mecoli CA; Lloyd TE; Danoff SK; Christopher-Stine L; Mammen AL
Arthritis Rheumatol; 2022 Mar; 74(3):508-517. PubMed ID: 34480833
[TBL] [Abstract][Full Text] [Related]
53. Autoantibody evaluation in idiopathic inflammatory myopathies.
Tebo AE
Adv Clin Chem; 2024; 120():45-67. PubMed ID: 38762242
[TBL] [Abstract][Full Text] [Related]
54. Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera.
Cavazzana I; Fredi M; Ceribelli A; Mordenti C; Ferrari F; Carabellese N; Tincani A; Satoh M; Franceschini F
J Immunol Methods; 2016 Jun; 433():1-5. PubMed ID: 26906088
[TBL] [Abstract][Full Text] [Related]
55. [Usefulness of autoantibodies for the diagnosis of autoimmune myopathies].
Allenbach Y; Benveniste O
Rev Neurol (Paris); 2013; 169(8-9):656-62. PubMed ID: 23642286
[TBL] [Abstract][Full Text] [Related]
56. Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies.
Mahler M; Betteridge Z; Bentow C; Richards M; Seaman A; Chinoy H; McHugh N
Front Immunol; 2019; 10():848. PubMed ID: 31114570
[No Abstract] [Full Text] [Related]
57. Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.
Larman HB; Salajegheh M; Nazareno R; Lam T; Sauld J; Steen H; Kong SW; Pinkus JL; Amato AA; Elledge SJ; Greenberg SA
Ann Neurol; 2013 Mar; 73(3):408-18. PubMed ID: 23596012
[TBL] [Abstract][Full Text] [Related]
58. Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease.
Sordet C; Goetz J; Sibilia J
Joint Bone Spine; 2006 Dec; 73(6):646-54. PubMed ID: 17110150
[TBL] [Abstract][Full Text] [Related]
59. Paraneoplastic myopathies.
Mammen AL
Handb Clin Neurol; 2024; 200():327-332. PubMed ID: 38494286
[TBL] [Abstract][Full Text] [Related]
60. Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.
Tansley SL; Betteridge ZE; Simou S; Jacques TS; Pilkington C; Wood M; Warrier K; Wedderburn LR; McHugh NJ;
J Rheumatol; 2017 Apr; 44(4):488-492. PubMed ID: 28202739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
